Cargando…

The interplay between androgens and the immune response in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a metabolic-reproductive-endocrine disorder that, while having a genetic component, is known to have a complex multifactorial etiology. As PCOS is a diagnosis of exclusion, standardized criteria have been developed for its diagnosis. The general consensus is that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shabbir, Sania, Khurram, Emaan, Moorthi, Vedhika Sathya, Eissa, Youssef Tamer Hassan, Kamal, Mohammad Azhar, Butler, Alexandra E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105935/ https://www.ncbi.nlm.nih.gov/pubmed/37062827 http://dx.doi.org/10.1186/s12967-023-04116-4

Ejemplares similares

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2022)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial
por: Nadjarzadeh, Azadeh, et al.
Publicado: (2013)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
por: Batóg, Gabriela, et al.
Publicado: (2023)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Androgen receptor gene mutations in 258 Han Chinese patients with polycystic ovary syndrome
por: Tian, Lifeng, et al.
Publicado: (2021)

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
por: Ding, Haigang, et al.
Publicado: (2021)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia
por: Ghaneei, Azam, et al.
Publicado: (2015)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)
por: Rae, Mick, et al.
Publicado: (2013)

Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome
por: Dogan, Bercem Aycicek, et al.
Publicado: (2014)

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
por: Sanchez-Garrido, Miguel A., et al.
Publicado: (2020)

Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
por: Kollmann, Martina, et al.
Publicado: (2019)

Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes
por: Polak, Aleksandra Maria, et al.
Publicado: (2020)

Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
por: Han, Qixin, et al.
Publicado: (2021)

Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
por: Rahmatnezhad, Leili, et al.
Publicado: (2023)

Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome
por: Dumesic, Daniel A, et al.
Publicado: (2023)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

Immune Dysfunction in Polycystic Ovary Syndrome
por: Banerjee, Soma, et al.
Publicado: (2023)

Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome
por: Nam, Hyoun, et al.
Publicado: (2015)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

Androgen Action in the Ovary
por: Franks, Stephen, et al.
Publicado: (2018)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome
por: Kushnir, Vitaly A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_to8tcd27s7g5jur8msnmd217gk